StonvexLoading…
StonvexStonvexStonvexCore line items from STE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $4.35B | $2.85B | $1.39B | $5.46B |
Operating Income | $785.00M | $511.80M | $246.00M | $866.64M |
Net Income | $562.10M | $369.20M | $177.40M | $614.64M |
EPS (Diluted) | $5.69 | $3.74 | $1.79 | $6.20 |
Total Assets | $10.59B | $10.41B | $10.40B | $10.15B |
Total Liabilities | $3.42B | $3.39B | $3.44B | $3.53B |
Cash & Equivalents | $423.70M | $319.20M | $279.70M | $171.70M |
Free Cash Flow OCF − CapEx | $727.20M | $527.70M | $326.40M | $778.00M |
Shares Outstanding | 98.10M | 98.10M | 98.50M | 98.30M |